Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

  title={Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients},
  author={Maxime Taquet and Rebecca Sillett and Lena Zhu and Jacob Mendel and I. Camplisson and Quentin Dercon and Paul Harrison},
  journal={The Lancet. Psychiatry},
  pages={815 - 827}

Figures and Tables from this paper

Long-term mental health outcomes after SARS-CoV-2 infection: prospective cohort study

People who survived COVID-19 were at increased risk of psychiatric outcomes and related psychotropic medications and participants who were fully vaccinated had a lower risk of mental health outcomes compared to those infected when unvaccinated or partially vaccinated.

Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US

The authors' agnostic screen of time stamped EHR data uncovered a plethora of PASC-associated diagnoses across many categories and highlighted a complex arrangement of presenting and likely pre-disposing features -- the latter with a potential for risk stratification approaches.

Follow-Up of a Cohort of Patients with Post-Acute COVID-19 Syndrome in a Belgian Family Practice

Brain single-photon emission computed tomography (SPECT-CT) was used in thirty-two patients with a high severity index and a highly impaired functional status, demonstrating vascular encephalopathy in twenty nine patients and supporting the hypothesis of a persistent cerebral vascular flow disorder in post COVID-19 condition.

Understanding the Post COVID-19 Condition (Long COVID) in Adults and the Expected Burden for Ontario

There remains significant uncertainty in the definition, magnitude of prevalence, causes, risk factors, prevention, and prognosis of the post COVID-19 condition, as well as its impact on people’s quality of life, function, and ability to work.

Characteristics and Outcomes of Cryptococcosis among Patients with and without COVID-19

After propensity score matching, patients with COVID-19 had higher rates of neoplastic disease, heart failure, chronic kidney disease, and glucocorticoid use but did not experience worse outcomes compared to those without CO VID-19.

Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan

The transitional changes in long COVID symptoms caused by the two variants were characterized and patients infected in the Omicron-dominant period had significantly fewer hospitalizations, milder illnesses, more vaccinations and earlier visit to the CAC.

Neurological consequences of COVID-19

The relationship between SARS-CoV-2 and the nervous system is not only a cause of neurological complications in previously healthy individuals but also directly and indirectly affects the courses of many nervous system diseases.

Neurological post‐acute sequelae of SARS‐CoV‐2 infection (PASC)

This review discusses the currently available information on PASC and highlights the neurological sequelae of COVID‐19 infection and provides clinical suggestions for diagnosing and caring for PASC patients based on the outpatient clinic experience.

Possible Application of Melatonin in Long COVID

The application of melatonin as a neuroprotective agent to control cognitive deterioration (“brain fog”) and pain in the ME/CFS syndrome-like documented in long COVID is discussed.



Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

The results indicate the excess risk of developing new clinical sequelae after the acute phase of SARS-CoV-2 infection, including specific types of sequelae less commonly seen in other viral illnesses.

Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19

This large, matched cohort study indicates substantial new-onset post COVID-19 morbidity in pediatric and adult populations and three domains (physical health, mental health, physical/mental overlap domain).